Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 32Sarcoma 23Lymphoid 2Other hematologic neoplasm 1Head & Neck 1

Conditions

Oligodendroglioma 1Medulloblastoma 1Lymphoma 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Cisplatin 3selpercatinib 2pembrolizumab 2Etoposide 2Carboplatin 2regorafenib 1pentetreotide 1pazopanib 1etoposide phosphate 1epothilone B 1entrectinib 1durvalumab 1carbon-11 methionine 1cabozantinib 1aflibercept 1Thiotepa 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Nivolumab 1NEO212 1Molecular Diagnostic Techniques 1Methionine 1MLN 8237 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Carmustine × Head & Neck × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡